Ultra-Sensitive Vector Magnetometer for Magnetocardiographic Mapping

Clinical magnetocardiography: the unshielded bet-past, present, and future

Magnetocardiography (MCG), which is nowadays 60 years old, has not yet been fully accepted as a clinical tool. Nevertheless, a large body of research and several clinical trials have demonstrated its reliability in providing additional diagnostic electrophysiological information if compared with conventional non-invasive electrocardiographic methods. Since the beginning, one major objective difficulty has been the need to clean the weak cardiac magnetic signals from the much higher environmental noise, especially that of urban and hospital environments. The obvious solution to record the magnetocardiogram in highly performant magnetically shielded rooms has provided the ideal setup for decades of research demonstrating the diagnostic potential of this technology. However, only a few clinical institutions have had the resources to install and run routinely such highly expensive and technically demanding systems. Therefore, increasing attempts have been made to develop cheaper alternatives to improve the magnetic signal-to-noise ratio allowing MCG in unshielded hospital environments. In this article, the most relevant milestones in the MCG's journey are reviewed, addressing the possible reasons beyond the currently long-lasting difficulty to reach a clinical breakthrough and leveraging the authors' personal experience since the early 1980s attempting to finally bring MCG to the patient's bedside for many years thus far. Their nearly four decades of foundational experimental and clinical research between shielded and unshielded solutions are summarized and referenced, following the original vision that MCG had to be intended as an unrivaled method for contactless assessment of the cardiac electrophysiology and as an advanced method for non-invasive electroanatomical imaging, through multimodal integration with other non-fluoroscopic imaging techniques. Whereas all the above accounts for the past, with the available innovative sensors and more affordable active shielding technologies, the present demonstrates that several novel systems have been developed and tested in multicenter clinical trials adopting both shielded and unshielded MCG built-in hospital environments. The future of MCG will mostly be dependent on the results from the ongoing progress in novel sensor technology, which is relatively soon foreseen to provide multiple alternatives for the construction of more compact, affordable, portable, and even wearable devices for unshielded MCG inside hospital environments and perhaps also for ambulatory patients.

A customized control and readout device for vector magnetometers based on nitrogen-vacancy centers

A customized control and readout device, which is developed to perform real-time measurement for vector magnetometers based on nitrogen-vacancy centers, is presented in this paper. A dual-channel analog-to-digital-converter chip, which has a 25 MSa/s sampling rate and a 16 bits amplitude resolution, is integrated for analog signal acquisition. The data processing and the system control are realized using a Xilinx Kirtex-7 field-programmable-gate-array chip. Eight independent lock-in modules, a four-channel proportional-integral-derivative controller, a reference generator, and a vector field reconstruction module are integrated with the Kirtex-7 device in order to perform the real-time vector magnetic field measurement. The device has a bright future to be applied in practical applications.

Evolution of MEG: A first MEG-feasible fluxgate magnetometer

In the current article, we present the first solid‐state sensor feasible for magnetoencephalography (MEG) that works at room temperature. The sensor is a fluxgate magnetometer based on yttrium‐iron garnet films (YIGM). In this feasibility study, we prove the concept of usage of the YIGM in terms of MEG by registering a simple brain induced field—the human alpha rhythm. All the experiments and results are validated with usage of another kind of high‐sensitive magnetometers—optically pumped magnetometer, which currently appears to be well‐established in terms of MEG.

Vector magnetocardiography measurement with a compact elliptically polarized laser-pumped magnetometer

We report on a practical approach to vector biomagnetism measurement with an optically pumped magnetometer for measuring total magnetic field intensity. Its application to vector magnetocardiography is experimentally demonstrated with a compact elliptically polarized laser-pumped M _x atomic magnetometer (EPMx OPM). The approach is proved to be effective and able to provide more complete cardiac magnetic information. The cardiac magnetic vectors are displayed in three-dimensional space in the form of magnetic vector loops. The sensor configuration and the image processing method here are expected to form further values, especially for multi-channel vector biomagnetism measurement, clinical diagnosis, and field source reconstruction.